745P Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC)

詳細情報 詳細情報について

• CRID

  1870302167744132352

• DOI

  10.1016/j.annonc.2020.08.817

• ISSN

  09237534

• データソース種別

  • OpenAIRE